CD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital)

N/A

Report date: 2025/04/24 20:00:10

Base Information

Drug NameCD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of Action5'-nucleotidase modulatorsAXL receptor tyrosine kinase modulatorsT lymphocyte replacements
Targets5'-nucleotidaseAXL receptor tyrosine kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPla General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesPla General Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A